SCHEMBL22164596

SCHEMBL22164596

Cn1nc2ccc(Br)cc2c1CCO

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HTT P42858 6/20 0.39
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ CASP3 P42574 3/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ MAPK8 P45983 1/20 0.35
▸ ALDH1A1 P00352 5/20 0.34
▸ RXFP1 Q9HBX9 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ ATM Q13315 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CCNC P24863 1/20 0.33
▸ CDK8 P49336 1/20 0.33
▸ MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20450508 0.87 LMNA (0.38) LMNAMAPTHTTKMT2AMEN1
SCHEMBL14077456 0.82 HTT (0.42) LMNAMAPTHTTCASP3MAPK8
SCHEMBL27872993 0.81 CYP1A2 (0.38) LMNAHTTKMT2AMEN1CASP3
SCHEMBL1047655 0.80 ALDH1A1 (0.36) LMNAMAPTHTTKMT2AMEN1
SCHEMBL30620821 0.79 HTT (0.36) LMNAMAPTHTTCASP3MAPK8
SCHEMBL13106339 0.73 CASP3 (0.48) LMNAHTTKMT2AMEN1CASP3
SCHEMBL22164595 0.72 HTT (0.41) LMNAMAPTHTTKMT2AMEN1
SCHEMBL1048915 0.71 CASP3 (0.40) LMNAHTTKMT2AMEN1CASP3
SCHEMBL17459798 0.71 HTT (0.42) LMNAHTTCASP3MAPK8ALDH1A1
SCHEMBL13106483 0.71 CASP3 (0.40) LMNAHTTCASP3L3MBTL1MAPK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3902803-A1 AZA-HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREATING CANCER Les Laboratoires Servier SAS (FR) 2021-11-03 — — EP disclosed
WO-2020139991-A1 AZA-HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREATING CANCER AGIOS PHARMACEUTICALS, INC. (US) 2020-07-02 — — WO disclosed
Send feedback